ADC Therapeutics S.A.

ADCT · NYSE
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$41-$57-$39-$31
Dep. & Amort.$0$1$1$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$2$2$2$3
Change in WC$0$22-$30$6
Other Non-Cash$9$7$9-$0
Operating Cash Flow-$30-$24-$56-$22
Investing Activities
PP&E Inv.$0$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0-$0-$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued-$0$0$0$0
Stock Repurch.$0-$0$0-$1
Dividends Paid$0$0$0$0
Other Fin. Act.$0$94$0$0
Financing Cash Flow-$0$94$0-$1
Forex Effect$0$0$0-$0
Net Chg. in Cash-$30$70-$56-$23
Supplemental Information
Beg. Cash$265$195$251$274
End Cash$235$265$195$251
Free Cash Flow-$30-$24-$57-$22
ADC Therapeutics S.A. (ADCT) Financial Statements & Key Stats | AlphaPilot